Key Developments: CVS Caremark Corp (CVS)
58.70USD
22 May 2013
$-0.81 (-1.36%)
$59.51
$59.44
$59.94
$58.49
5,992,781
5,704,399
$60.66
$43.30
Latest Key Developments (Source: Significant Developments)
Cvs Caremark Corp Raises Low End Of Prior FY 2013 EPS Guidance To A Range In Line With Analysts' Estimates; Issues Q2 2013 EPS Guidance In Line With Analysts' Estimates
Cvs Caremark Corp announced that for fiscal 2013, it expects to deliver adjusted EPS of $3.89 to $4.00 and GAAP diluted earnings per share from continuing operations of $3.64 to $3.75 per share in fiscal 2013. For second quarter of 2013, it expects adjusted EPS guidance of $0.94 to $0.97 and GAAP diluted EPS from continuing operations guidance of $0.88 to $0.91. According to I/B/E/S Estimates, analysts on an average were expecting the Company to report EPS of $3.97 for fiscal 2013; EPS of $0.94 for second quarter of 2013. Full Article
Cvs Caremark Corp Gets Contract To Serve 1.1 Million CareFirst Members-Reuters
Reuters reported that Cvs Caremark Corp is set to provide pharmacy benefit and other services for 1.1 million CareFirst BlueCross BlueShield members starting next year. The three-year contract is the latest win for CVS Caremark, which has been gaining ground with its combined approach of running retail drugstores and a pharmacy benefits management business. CareFirst announced the contract, which begins on January 1, 2014. It said the contract covers its commercial and Medicare Part D members. Full Article
Cvs Caremark Corp Announces Quarterly Dividend
Cvs Caremark Corp announced that its board of directors has approved a quarterly dividend of $0.225 (22.5 cents) per share on the corporation's common stock. The dividend is payable on May 3, 2013, to holders of record on April 23, 2013. Full Article
Cvs Caremark Corp Buys Drogaria Onofre-Reuters
Reuters reported that Cvs Caremark Corp said it has bought Drogaria Onofre, Brazil's drugstore chain. Full Article
Cvs Caremark Corp Raises FY 2013 EPS Guidance
Cvs Caremark Corp raised its earnings guidance for fiscal 2013 to reflect the anticipated two cents per share of EPS accretion related to the debt tender and refinancing that was executed during the fourth quarter of last year. The Company currently expects to deliver Adjusted EPS of $3.86 to $4.00 and GAAP diluted earnings per share from continuing operations of $3.61 to $3.75 per share in fiscal 2013. According to I/B/E/S Estimates, analysts on an average were expecting the Company to report EPS of $3.94 for fiscal 2013. Full Article
Cvs Caremark Corp's MinuteClinic And Barnabas Health Enter Into Clinical Collaboration in Monmouth and Ocean Counties
MinuteClinic, the retail health care division of Cvs Caremark Corp and Barnabas Health in New Jersey announced that they have signed a clinical collaboration to enhance access to high quality, affordable health care services in Monmouth and Ocean counties. Under the agreement, Barnabas Health physicians will serve as medical directors for three MinuteClinic walk-in medical clinics open seven days a week inside select CVS/pharmacy stores in Jackson, Manalapan and Marlboro, New Jersey. In addition, MinuteClinic and Barnabas Health will collaborate on patient education and disease management initiatives and will inform patients of the services each provide. Barnabas Health will accept patients who need a level of care that is not provided among MinuteClinic services. Signage at MinuteClinic locations will inform patients that each site has an affiliation with Barnabas Health. Full Article
Cvs Caremark Corp Issues FY 2013 EPS Guidance In Line With Analysts' Estimates-Conference Call
Cvs Caremark Corp announced that for fiscal 2013, it expects adjusted earnings per share from continuing operations to be in the range of $3.84 to $3.98. According to I/B/E/S Estimates, analysts are expecting the Company to report EPS of $3.94 for fiscal 2013. Full Article
Fitch Affirms CVS Caremark at 'BBB+'; Outlook Stable
Fitch Ratings announced that it has affirmed its ratings on CVS Caremark Corp, including the long-term Issuer Default Rating (IDR) at 'BBB+'. The Rating Outlook is Stable. Full Article
Cvs Caremark Corp Sees FY 2012 EPS Guidance At High End Of Prior Range-Conference Call
Cvs Caremark Corp announced that it expects to deliver approximately $0.15 more than the high end of initial fiscal 2012 EPS guidance range. Full Article
Cvs Caremark Corp Announces 38% Dividend Increase
Cvs Caremark Corp announced that its Board of Directors has approved an increase in its quarterly dividend of approximately 38%, to $0.225 per share on the common stock of the Company, payable February 4, 2013, to holders of record on January 24, 2013. This increase translates into an annual rate of 90 cents per share, up 25 cents per share from the previous annual rate of 65 cents. Full Article
CVS Caremark profit rises, helped by generics, flu season
- CVS Caremark Corp posted a higher than expected first-quarter profit on Wednesday, helped by more profitable generic drugs on the market and a severe cold and flu season that boosted sales at its drugstores.
Earnings vs. 
Estimates
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
